Prevalence of Abnormal Insulin (n = 14)
| First Author . | Country . | Ages (y) . | N . | Definition of Abnormal . | Subgroup (eg, M/F) . | Total . | Healthy . | Overweight . | Class I . | Class II . | Class III . | P . | Notes . | Weight Definitions . | Population Info . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bell | Australia | 6–13 | 283 | >12 mIU/L | 8.0 | 19.5 | 38.9 | <.001 | |||||||
| Salvatore | USA | 3–18 | 101 | >10 | 0 | 47.4 | 56.5 | 72.2 | .301 | Pediatric gastroenterology patients | |||||
| O’Hara | USA | 3–19 | 382 | >20 mIU/mL | 42 | 29 | 34 | 40 | 57 | NS | Stage 3 pediatric weight management program patients | ||||
| Marcus | USA | Mean 11.2 | 1305 | >30 | 10.5 | 35.7 | <.0001 | ||||||||
| Michalsky | USA | 13–19 | 242 | >17.0 ulU/mL | 74.1 | 73.9 | 74.0 | 75.0 | >.99 | 1: 30 < 50 BMI, 2: 50 < 60; 3: >60 | Bariatric surgery patients | ||||
| Yoshinaga | Japan | 6–12 | 471 | >90th | Males | 20.5 | 47.7 | <.05 | |||||||
| Females | 45 | 60.8 | <.05 | ||||||||||||
| Maximova | Canada | 6–11 | 2087 | >75th | 6–11 y | 18.0 | 50.2 | NR | |||||||
| 12–19 y | 11.6 | 49.3 | NR | ||||||||||||
| Baranowski | USA | Mean 13.6 | 1740 | >30 uU/mL | 36.2 | 16.0 | 36.2 | 72.3 | NR | ||||||
| Caserta | Italy | 11–13 | 646 | >11 males, >13.2 females | Males | 12.4 | 25.6 | 60.4 | <.05 | ||||||
| Females | 11.2 | 38.2 | 65.5 | <.05 | |||||||||||
| Marcus | USA | Mean 11.8 | 6358 | >30 uU/mL | 0.8 | 3.0 | 13.4 | 40.0 | <.001 | ||||||
| Lambert | Canada | 9–16 | 3613 | >38 9 y, >60 13–16 y | Males | 11.3 | 37.2 | 72.1 | <.0001 | ||||||
| Females | 23.2 | 46.3 | 80.1 | <.0001 | |||||||||||
| Valery | Australia | 5–17 | 158 | <15.0 mU/L | 30 | 56 | .021 | Indigenous youth | |||||||
| Gunes | USA | 11–18 | 363 | >30 uU/mL | Males | 6.6 | 12.8 | .347 | Adolescent clinic patients | ||||||
| Females | 1.7 | 24.5 | <.001 | Adolescent clinic patients | |||||||||||
| Stolzman | USA | 12–17 | 62 | >15 uU/mL | 3 | 33 | <.05 | Community recruitment |
| First Author . | Country . | Ages (y) . | N . | Definition of Abnormal . | Subgroup (eg, M/F) . | Total . | Healthy . | Overweight . | Class I . | Class II . | Class III . | P . | Notes . | Weight Definitions . | Population Info . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bell | Australia | 6–13 | 283 | >12 mIU/L | 8.0 | 19.5 | 38.9 | <.001 | |||||||
| Salvatore | USA | 3–18 | 101 | >10 | 0 | 47.4 | 56.5 | 72.2 | .301 | Pediatric gastroenterology patients | |||||
| O’Hara | USA | 3–19 | 382 | >20 mIU/mL | 42 | 29 | 34 | 40 | 57 | NS | Stage 3 pediatric weight management program patients | ||||
| Marcus | USA | Mean 11.2 | 1305 | >30 | 10.5 | 35.7 | <.0001 | ||||||||
| Michalsky | USA | 13–19 | 242 | >17.0 ulU/mL | 74.1 | 73.9 | 74.0 | 75.0 | >.99 | 1: 30 < 50 BMI, 2: 50 < 60; 3: >60 | Bariatric surgery patients | ||||
| Yoshinaga | Japan | 6–12 | 471 | >90th | Males | 20.5 | 47.7 | <.05 | |||||||
| Females | 45 | 60.8 | <.05 | ||||||||||||
| Maximova | Canada | 6–11 | 2087 | >75th | 6–11 y | 18.0 | 50.2 | NR | |||||||
| 12–19 y | 11.6 | 49.3 | NR | ||||||||||||
| Baranowski | USA | Mean 13.6 | 1740 | >30 uU/mL | 36.2 | 16.0 | 36.2 | 72.3 | NR | ||||||
| Caserta | Italy | 11–13 | 646 | >11 males, >13.2 females | Males | 12.4 | 25.6 | 60.4 | <.05 | ||||||
| Females | 11.2 | 38.2 | 65.5 | <.05 | |||||||||||
| Marcus | USA | Mean 11.8 | 6358 | >30 uU/mL | 0.8 | 3.0 | 13.4 | 40.0 | <.001 | ||||||
| Lambert | Canada | 9–16 | 3613 | >38 9 y, >60 13–16 y | Males | 11.3 | 37.2 | 72.1 | <.0001 | ||||||
| Females | 23.2 | 46.3 | 80.1 | <.0001 | |||||||||||
| Valery | Australia | 5–17 | 158 | <15.0 mU/L | 30 | 56 | .021 | Indigenous youth | |||||||
| Gunes | USA | 11–18 | 363 | >30 uU/mL | Males | 6.6 | 12.8 | .347 | Adolescent clinic patients | ||||||
| Females | 1.7 | 24.5 | <.001 | Adolescent clinic patients | |||||||||||
| Stolzman | USA | 12–17 | 62 | >15 uU/mL | 3 | 33 | <.05 | Community recruitment |
NR, not reported; NS, not significant.